MA54823A - Composé hétérocyclique et son utilisation - Google Patents
Composé hétérocyclique et son utilisationInfo
- Publication number
- MA54823A MA54823A MA054823A MA54823A MA54823A MA 54823 A MA54823 A MA 54823A MA 054823 A MA054823 A MA 054823A MA 54823 A MA54823 A MA 54823A MA 54823 A MA54823 A MA 54823A
- Authority
- MA
- Morocco
- Prior art keywords
- heterocyclic compound
- heterocyclic
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019010536 | 2019-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA54823A true MA54823A (fr) | 2022-04-27 |
Family
ID=71736449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA054823A MA54823A (fr) | 2019-01-24 | 2020-01-23 | Composé hétérocyclique et son utilisation |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220089525A1 (fr) |
EP (1) | EP3915638A4 (fr) |
JP (1) | JPWO2020153414A1 (fr) |
MA (1) | MA54823A (fr) |
WO (1) | WO2020153414A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019189945A1 (fr) | 2018-03-28 | 2019-10-03 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique et son utilisation |
JP2021050161A (ja) | 2019-09-25 | 2021-04-01 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319498B1 (en) | 1995-03-14 | 2001-11-20 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
DK0929574T3 (da) | 1996-08-27 | 2005-10-31 | Praecis Pharm Inc | Modulatorer af beta-amyloidpeptidaggregering, som omfatter D-aminosyrer |
US6545127B1 (en) | 1999-06-28 | 2003-04-08 | Oklahoma Medical Research Foundation | Catalytically active recombinant memapsin and methods of use thereof |
TWI262185B (en) | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
US20020151534A1 (en) | 2001-02-02 | 2002-10-17 | Ries Uwe Joerg | Antithrombotic compounds |
DE10111842A1 (de) | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel |
WO2002080899A1 (fr) | 2001-03-30 | 2002-10-17 | Eisai Co., Ltd. | Agent de traitement de maladie digestive |
EP1375472A4 (fr) | 2001-03-30 | 2008-12-10 | Eisai R&D Man Co Ltd | Compose de benzene et sel de ce compose |
AU2002338334B8 (en) * | 2001-04-03 | 2008-09-18 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists |
EP1987004A2 (fr) * | 2006-02-16 | 2008-11-05 | Boehringer Ingelheim International GmbH | Pyridineamides substitués pouvant être employés en tant qu'inhibiteurs d'époxyde hydrolase soluble |
JP2010120852A (ja) | 2007-03-09 | 2010-06-03 | Daiichi Sankyo Co Ltd | 新規なジアミド誘導体 |
WO2012158691A1 (fr) | 2011-05-19 | 2012-11-22 | The Board Of Trustees Of The Leland Stanford Junior University | Composés antiprolifératifs et procédés pour leur utilisation |
ES2626811T3 (es) | 2013-03-08 | 2017-07-26 | Becton, Dickinson And Company | Dispositivo de bloqueo de acceso de jeringa intravenosa (IV) |
CA2903572A1 (fr) | 2013-03-15 | 2014-10-23 | Epizyme, Inc. | Composes de benzene substitues |
EP3239150B1 (fr) | 2014-12-24 | 2020-02-05 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique |
TW201718574A (zh) | 2015-08-12 | 2017-06-01 | 美國禮來大藥廠 | Cgrp受體拮抗劑 |
TWI636041B (zh) | 2015-08-12 | 2018-09-21 | 美國禮來大藥廠 | Cgrp受體拮抗劑 |
JP2019514860A (ja) | 2016-04-08 | 2019-06-06 | シンジェンタ パーティシペーションズ アーゲー | 殺微生物性オキサジアゾール誘導体 |
-
2020
- 2020-01-23 MA MA054823A patent/MA54823A/fr unknown
- 2020-01-23 US US17/310,164 patent/US20220089525A1/en active Pending
- 2020-01-23 WO PCT/JP2020/002216 patent/WO2020153414A1/fr unknown
- 2020-01-23 JP JP2020568192A patent/JPWO2020153414A1/ja active Pending
- 2020-01-23 EP EP20744243.5A patent/EP3915638A4/fr active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220089525A1 (en) | 2022-03-24 |
JPWO2020153414A1 (ja) | 2021-12-02 |
WO2020153414A1 (fr) | 2020-07-30 |
EP3915638A1 (fr) | 2021-12-01 |
EP3915638A4 (fr) | 2022-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA43963A (fr) | Composé de pipéridine substituée et son utilisation | |
JP1640198S (ja) | イヤホンケース | |
UA42395S (uk) | Футляр | |
ZA202001340B (en) | Heterocyclic compound and use thereof | |
JP1642767S (ja) | イヤホン | |
MA45940A (fr) | Composé hétérocyclique | |
ZA202106304B (en) | Heterocyclic compound and use thereof | |
DK3513617T3 (da) | Håndtering af PDCP under genetablering af forbindelse | |
MA52214A (fr) | Composé hétérocyclique et son utilisation | |
DK4018074T3 (da) | Borebrøndindretning | |
DK3672948T3 (da) | Pyridinamin-pyridon- og pyrimidinamin-pyridonforbindelser | |
MA50093A (fr) | Composé pentacyclique | |
KR20220035499A (ko) | 보호 소자 | |
MA54823A (fr) | Composé hétérocyclique et son utilisation | |
MA49766A (fr) | Benzothiazoles et composés connexes | |
MA52297A (fr) | Composé hétérocyclique | |
DK3556683T3 (da) | Fastgørelsesbånd | |
DK3755872T3 (da) | Borehulsindretning | |
MA55221A (fr) | Composé hétérocyclique pentacyclique | |
DE112019003181A5 (de) | Stufenbohrer | |
MA54243A (fr) | Composé de 1,3,4-oxadiazolone et médicament | |
DK3672967T3 (da) | Azaindolylpyridon- og diazaindolylpyridonforbindelser | |
IT201900025840A1 (it) | Composti isotiocianati e isoselencianati | |
DK3567831T3 (da) | Kommunikationshåndtering | |
DE112019005279A5 (de) | Stufenbohrer |